Published online Jun 6, 2023. doi: 10.12998/wjcc.v11.i16.3664
Peer-review started: December 27, 2022
First decision: March 24, 2023
Revised: March 29, 2023
Accepted: April 27, 2023
Article in press: April 27, 2023
Published online: June 6, 2023
Processing time: 156 Days and 23.1 Hours
Core Tip: Kikuchi-Fujimoto disease or Kikuchi disease described originally in young Japanese women is a rare benign cause of fever and lymphadenopathy usually involving cervical lymph nodes. The disease has been reported worldwide in both genders across ethnic and age groups. Histopathologically, histiocytic necrotizing lymphadenitis is characteristic and needs differentiation from more serious conditions such as malignant lymphoma in acute or subacute form. Its long-term prognosis is favorable albeit long-term follow-up is recommended because of a rare but increased risk of developing systemic lupus erythematosus/other autoimmune disorders. Patients with a severe or recurrent disease need treatment with nonsteroidal anti-inflammatory drugs, systemic corticosteroids, and/or other immunomodulators.
